Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease

Por Toth, Peter P
Publicado no Vasc Health Risk Manag (2014)

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era

Por Toth, Peter P
Publicado no Vasc Health Risk Manag (2016)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease

Por Toth, Peter P
Publicado no Vasc Health Risk Manag (2016)

Comprehensive cardiovascular medicine in the primary care setting

Por Toth, Peter P., Cannon, Christopher P.
Publicado em 2011

Dyslipidemia in women: etiology and management

Por Phan, Binh An P, Toth, Peter P
Publicado em 2014

Ezetimibe therapy: mechanism of action and clinical update

Por Phan, Binh An P, Dayspring, Thomas D, Toth, Peter P
Publicado em 2012

Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis

Por Toth Peter P, Zarotsky Victoria, Sullivan Jane M, Laitinen Dave
Publicado em 2009-05-01

Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis

Por Toth, Peter P, Zarotsky, Victoria, Sullivan, Jane M, Laitinen, Dave
Publicado em 2009

Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy

Por Toth, Peter P, Thakker, Kamlesh M, Jiang, Ping, Padley, Robert J
Publicado em 2012

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

Por Chiquette, Elaine, Toth, Peter P, Ramirez, Gilbert, Cobble, Michael, Chilton, Robert
Publicado em 2012

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Por Blom, Dirk J, Dent, Ricardo, Castro, Rita C, Toth, Peter P
Publicado no Vasc Health Risk Manag (2016)

Therapeutic lipidology

Por Davidson, Michael, Toth, Peter P., Maki, Kevin C., Gotto, Antonio M., Jr.
Publicado em c200

Molecular mechanisms of statin intolerance

Por Gluba-Brzozka, Anna, Franczyk, Beata, Toth, Peter P., Rysz, Jacek, Banach, Maciej
Publicado no Arch Med Sci (2016)

Achieving Secondary Prevention Low-Density Lipoprotein Particle Concentration Goals Using Lipoprotein Cholesterol-Based Data

Por Mathews, Simon C., Mallidi, Jaya, Kulkarni, Krishnaji, Toth, Peter P., Jones, Steven R.
Publicado em 2012

PCSK9 inhibitor access barriers—issues and recommendations: Improving the access process for patients, clinicians and payers

Por Baum, Seth J., Toth, Peter P., Underberg, James A., Jellinger, Paul, Ross, Joyce, Wilemon, Katherine
Publicado no Clin Cardiol (2017)

The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus

Por Toth, Peter P, Simko, Robert J, Palli, Swetha Rao, Koselleck, Dawn, Quimbo, Ralph A, Cziraky, Mark J
Publicado em 2012

Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Por Gluba-Brzózka, Anna, Michalska-Kasiczak, Marta, Franczyk, Beata, Nocuń, Marek, Toth, Peter P., Banach, Maciej, Rysz, Jacek
Publicado no Lipids Health Dis (2016)

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile

Por Martin, Seth S., Blaha, Michael J., Elshazly, Mohamed B., Toth, Peter P., Kwiterovich, Peter O., Blumenthal, Roger S., Jones, Steven R.
Publicado no JAMA (2013)

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy

Por Insull, William, Toth, Peter P, Superko, H Robert, Thakkar, Roopal B, Krause, Scott, Jiang, Ping, Parreno, Rhea A, Padley, Robert J
Publicado em 2010

Is Isolated Low HDL-C a CVD Risk Factor?: New Insights from the Framingham Offspring Study

Por Bartlett, Jacquelaine, Predazzi, Irene M., Williams, Scott M., Bush, William S., Kim, Yeunjung, Havas, Stephen, Toth, Peter P., Fazio, Sergio, Miller, Michael
Publicado no Circ Cardiovasc Qual Outcomes (2016)